Patients with kidney stones. Calculus of kidney
Conditions
Interventions
Intervention 1: Intervention group: The intervention group (n = 30) received a pearl 400 IU vit E and standard treatment based on urine metabolic evaluation for 8 weeks. Intervention 2: Control group
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Age 18-65 years Literate history of renal stone
Exclusion criteria
Exclusion criteria: primary hyperoxaluria ( urine 24 h oxalate more than 80 mg/24 h ) or enteric hyperoxaluria changing the dose or initiating potassium citrate during study use of drugs with any effect on oxalate eg B6 Patients with diabetes, Hypertension or renal disease pregnancy and lactation history of cystinuria history of Inflamatory bowel disease history of hyperparathyroidism use of vitamin supplement or anti oxidants use of warfarin unwillingness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 24-hour urine citrate. Timepoint: At the start of the study and at the end of the study. Method of measurement: 24 h Urine collection.;24-hour urine oxalate. Timepoint: At the start of the study and at the end of the study. Method of measurement: 24 h Urine collection. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum Uric acid level. Timepoint: At the start of the study and at the end of the study. Method of measurement: blood sample.;Serum calcium level. Timepoint: At the start of the study and at the end of the study. Method of measurement: blood sample. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmirhesam Alirezaei
Shahid Beheshti University of Medical Sciences
Outcome results
None listed